On-Demand webinar
Summary:
Misuse of opioid drugs and subsequent addiction over the past two decades have led to the Opioid Crisis. Deleterious events promoting the opioid crisis include treatment of pain with concomitant lack of training for using addictive pain management medication, and the social and economic factors that provoke misuse and amplify overdose and death. The COVID-19 pandemic has also had a serious impact on many societal standards, and in general, how we live our everyday lives. This too promotes an increase in opioid misuse and the number of opioid-related overdoses. Since the year 2000, we have a seen a staggering 137% increase in drug overdose related deaths, and so the Centers for Disease Control (CDC) has labelled the opioid crisis a top public health challenge.
Speaking on these findings, Dr. Steven Noel, Ph.D., Senior Clinical Consultant at Siemens Healthineers, will help you:
- Understand the current status of the opioid crisis and how it came to epidemic proportions, gaining an appreciation of the epidemiology of the crisis; that is, the impact of pain management, prescription drug dispensing, licit and illicit drug proliferation and COVID-19.
- Discover the need for comprehensive drug testing, learning about opioid-related drug abuse testing.
- Gain insight into encouraging approaches to tame the opioid crisis and improve public health outcomes.
Speaker:
Steven A. Noel, PhD (DABCC), MT (ASCP)
Senior Clinical Consultant, Siemens Healthineers.
Dr. Noel is a board-certified Clinical Chemist,
receiving his doctorate from the Ohio State University. He has served in different capacities in
laboratory medicine throughout his 40-year career. As a Clinical Chemist, Dr. Noel served as
Technical Director in hospital and commercial laboratories. In addition, his career has led him to dual
roles as Technical and Operations Director, and he recently served as the VP of
Operations at a national toxicology laboratory.
Dr. Noel has published on clinical laboratory assay topics in
reproductive endocrinology, cholesterol metabolism and other disease states
involving immunoassay testing.
